By analyzing E. coli protein levels, scientists found a surplus of membrane shuttle proteins that may play a role in ...
Review of data from the trial found that the vaccine was not sufficiently effective at preventing invasive E coli disease ...
A Cornell University-led collaboration has uncovered the equipment that enables bacteria to survive exposure to antibiotics: a shuttling mechanism that helps a complex of proteins pump out a wide ...
Researchers have created a novel imaging-technology combination that can capture gene activity in individual bacteria in ...
The virus struck more layer and other commercial poultry farms, as well as backyard flocks in multiple states.
Every year, foodborne illnesses sicken 50 million Americans and claim an estimated 3,000 lives. The food safety system is governed by 15 different federal agencies responsible for the enforcement of ...
The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.
Hosted on MSN20h
Can You Flush Out A UTI By Drinking More Water?Urinary tract infections (UTIs) are common, especially in women, due to their shorter urethras. Drinking plenty of water ...
Early diagnosis and treatment can significantly reduce morbidity and mortality, help to limit disability and improve outcomes ...
AbbVie announced that the US FDA has approved aztreonam and avibactam (Emblaveo), in combination with metronidazole, for ...
11h
News Medical on MSNDead bacteria offer nutrients to neighbors through evolved enzymeDarwin's theory of natural selection provides an explanation for why organisms develop traits that help them survive and reproduce.
22h
Hosted on MSNJ&J stops Phase III trial of Sanofi’s E. Coli vaccine citing ‘disappointing’ resultsThe company said it will stop the Phase III trial of ExPEC after interim results found it failed to demonstrate efficacy over placebo.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results